Figure 4From: Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial The level of inflammatory markers. Data are means ± SD. □ week 0, ■ week 12. †Values were significantly different between the placebo and Q10-300 groups († P < 0.05). CRP, C-reactive protein; IL-6, interleukin-6; TNF-α, tumor necrosis factor-α.Back to article page